ATYR PHARMA, INC. (ATYR) Operating cash flow 2016–2025
ATYR PHARMA, INC. (ATYR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$62.0MFY2025 · since FY2016: -$52.9M → -$62.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.0M | +10.3% |
| FY2024 | -$69.1M | -108.1% |
| FY2023 | -$33.2M | +20.7% |
| FY2022 | -$41.9M | -26.6% |
| FY2021 | -$33.1M | -116.2% |
| FY2020 | -$15.3M | +23.5% |
| FY2019 | -$20.0M | +35.6% |
| FY2018 | -$31.1M | +26.7% |
| FY2017 | -$42.4M | +19.9% |
| FY2016 | -$52.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice